Correlation Between Serina Therapeutics and United Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Serina Therapeutics and United Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Serina Therapeutics and United Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Serina Therapeutics and United Therapeutics, you can compare the effects of market volatilities on Serina Therapeutics and United Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Serina Therapeutics with a short position of United Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Serina Therapeutics and United Therapeutics.

Diversification Opportunities for Serina Therapeutics and United Therapeutics

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Serina and United is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Serina Therapeutics and United Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on United Therapeutics and Serina Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Serina Therapeutics are associated (or correlated) with United Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of United Therapeutics has no effect on the direction of Serina Therapeutics i.e., Serina Therapeutics and United Therapeutics go up and down completely randomly.

Pair Corralation between Serina Therapeutics and United Therapeutics

Considering the 90-day investment horizon Serina Therapeutics is expected to under-perform the United Therapeutics. In addition to that, Serina Therapeutics is 1.6 times more volatile than United Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. United Therapeutics is currently generating about -0.08 per unit of volatility. If you would invest  35,958  in United Therapeutics on December 20, 2024 and sell it today you would lose (4,073) from holding United Therapeutics or give up 11.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Serina Therapeutics  vs.  United Therapeutics

 Performance 
       Timeline  
Serina Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Serina Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with conflicting performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
United Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days United Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's technical indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Serina Therapeutics and United Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Serina Therapeutics and United Therapeutics

The main advantage of trading using opposite Serina Therapeutics and United Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Serina Therapeutics position performs unexpectedly, United Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Therapeutics will offset losses from the drop in United Therapeutics' long position.
The idea behind Serina Therapeutics and United Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Correlations
Find global opportunities by holding instruments from different markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios